YOKNEAM, Israel, April 9, 2025 /PRNewswire/ -- Butterfly Medical, a medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), announced today the ...
Butterfly Medical has raised $21m in Series C funding for the development and potential commercialisation of its minimally invasive device for benign prostatic hyperplasia (BPH). This latest funding ...
The US Food and Drug Administration (FDA) has cleared Prodeon Medical’s implantable technology for treating lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The ...
For thousands of Jamaican men, the warning signs may begin quietly, getting up once or twice at night to urinate, waiting for the urine stream to start or noticing that the stream is no longer as ...
GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).